Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Centessa Pharmaceuticals (CNTA) Leases (2023 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Leases for 3 consecutive years, with $10.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Leases fell 8.44% to $10.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $10.3 million, a 8.44% decrease, with the full-year FY2024 number at $11.0 million, down 7.56% from a year prior.
  • Leases was $10.3 million for Q3 2025 at Centessa Pharmaceuticals, down from $10.5 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $12.3 million in Q2 2023 to a low of $10.3 million in Q3 2025.
  • A 3-year average of $11.4 million and a median of $11.5 million in 2024 define the central range for Leases.
  • Peak YoY movement for Leases: fell 4.93% in 2024, then dropped 8.44% in 2025.
  • Centessa Pharmaceuticals' Leases stood at $11.9 million in 2023, then fell by 7.56% to $11.0 million in 2024, then dropped by 6.52% to $10.3 million in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Leases are $10.3 million (Q3 2025), $10.5 million (Q2 2025), and $10.8 million (Q1 2025).